The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Next generation sequencing (NGS) in resectable non-small cell lung cancer (NSCLC): Therapeutic implications.
 
Valerie W. Rusch
Research Funding - Genelux (Inst)
 
Kay See Tan
No Relationships to Disclose
 
Amanda Ghanie
No Relationships to Disclose
 
Maria E. Arcila
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Raindance Technologies
 
William D. Travis
No Relationships to Disclose
 
David Randolph Jones
No Relationships to Disclose
 
Bernard J. Park
No Relationships to Disclose
 
James Huang
Research Funding - Bristol-Myers Squibb
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; AVEO; Boehringer Ingelheim; Celgene; GlaxoSmithKline; Merck; Novartis
Research Funding - Biomarin
 
David Michael Hyman
No Relationships to Disclose
 
David B. Solit
Honoraria - Loxo; Novartis; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics; Sequenom
 
Jose Baselga
No Relationships to Disclose
 
Marc Ladanyi
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - NCCN/Boehringer Ingelheim
 
Gregory J. Riely
Honoraria - Celgene
Consulting or Advisory Role - ARIAD; Mersana; Novartis; Novartis; Roche
Research Funding - GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Novartis